PLAUR and neoplasm: The ability to perform a non-invasive quantification of uPAR expression in different tissues as demonstrated by us could potentially enable use of an empirically based cut-off value, for example, differentiating normal tissue from tumour tissue and aggressive cancers from indolent tumours, in clinical settings.